未登录

Y

Youngjin Han

Asan Medical Center

H指数:27

被引数:2,874

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Angiopoietin-1 and Tie2-Based Dual Cell Therapy Enhances Antiangiogenic Barrier Function in a Retina-Mimetic Model for Neovascular Retinal Disease

血管生成素-1和Tie2为基础的双细胞疗法增强了血管生成抑制性屏障功能，在一个模拟视网膜新生血管性视网膜疾病的模型中。

Tissue Engineering and Regenerative Medicine

IF4.1

2025-07-210

PRE

Establishment of Immune-Evasive iPSCs from PBMCs Using B2M Knockout and CD47/HLA-E Overexpression

利用B2M基因敲除和CD47/HLA-E过表达从PBMCs建立免疫逃逸iPSCs

Tissue Engineering and Regenerative Medicine

IF4.1

2025-07-190

PRE

Unleashing the power of p53 mRNA therapeutics to suppress proliferation of p53 mutant tumors

CANCER RESEARCH

IF16.6

2024-04-050

PRE

Unraveling therapeutic potentials of mRNA-based cancer vaccine concurrently targeting heterogeneous KRAS mutant cancer

CANCER RESEARCH

IF16.6

2024-04-050

PRE

Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells

JOURNAL OF OVARIAN RESEARCH

IF4.2

2024-04-024

OAAI

Effects of abdominal aortic aneurysm on long-term survival in lung cancer patients

SCIENTIFIC REPORTS

IF3.9

2024-01-082

OAAI

Synthetic RNA Therapeutics in Cancer

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2023-08-016

OAAI

An mRNA-based cancer vaccine multi-targeting KRAS mutations inhibits tumor growth by increasing immune response in KRAS mutant LL/2 mouse model

CANCER RESEARCH

IF16.6

2023-04-140

PRE

BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors

BRAFV600E突变通过调节雌激素受体表达增强雌激素诱导的甲状腺癌转移潜能

ENDOCRINOLOGY AND METABOLISM

IF4.2

2022-12-316

OAAI

Density lowering effect of ovarian function suppression in premenopausal breast cancer patients who had no density change with one year of tamoxifen treatment (DELFINO study)

ANNALS OF ONCOLOGY

IF65.4

2022-09-010

PRE

Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer

IF10.1

2022-08-0141

OA

Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-166

OAAI

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers

JOURNAL OF OVARIAN RESEARCH

IF4.2

2022-06-076

OAAI

Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-129

OAAI

Cardiovascular morbidities in postoperative colorectal cancer patients

SCIENTIFIC REPORTS

IF3.9

2021-11-013

OAAI

Risk of female-specific cancers according to obesity and menopausal status in 2.7 million Korean women: Similar trends between Korean and Western women

LANCET REGIONAL HEALTH-WESTERN PACIFIC

IF8.1

2021-06-0115

OAAI

Enhanced Susceptibility to Breast Cancer in Korean Women With Elevated Serum Gamma-Glutamyltransferase Levels: A Nationwide Population-Based Cohort Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-276

OAAI

Impact of Chronic Kidney Disease Under Nephrology Care on Outcomes of Carotid Endarterectomy

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

IF6.8

2021-05-013

OAAI

Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer

恶性腹水的计算模型揭示了卵巢癌免疫微环境中的CCL5-SDC4相互作用

MOLECULAR CARCINOGENESIS

IF3.2

2021-03-1516

OAAI

Piceatannol Is Superior to Resveratrol at Suppressing Adipogenesis in Human Visceral Adipose-Derived Stem Cells

IF4.1

2021-02-1416

OAAI